Overview
Lobbying Costs
250,000€
Financial year: Apr 2017 - Mar 2018
Lobbyists (Full time equivalent)
1.5 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Astellas Pharma Europe Limited (APEL)
EU Transparency Register
726065718920-12 First registered on 24 Sep 2015
Goals / Remit
Providing high quality medicines in areas of high unmet medical need
Main EU files targeted
All relevant pharmaceutical and health care initiatives, including Falsified Medicines Directive, Organ supply Directive, European Commission Incentives Review, Member State collaboration in the area of medicines pricing, EUnetHTA, orphan disease legislation, European Medicines Agency and regulatory policy, etc.
Address
Head Office
2000 Hillswood Drive
Chertsey KT16 0RS
UNITED KINGDOMEU Office
Astellas Pharma SA
Parc Scientifique Erasme
Bruxelles 1070
BELGIUM -
People
Total lobbyists declared
2
Employment time Lobbyists 100% 1 50% 1 Lobbyists (Full time equivalent)
1.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 03 Oct 2018
Name Start date End Date Mélanie Yammine 14 Oct 2024 13 Oct 2025 Rachel DIXON 20 Sep 2023 14 Sep 2024 Melanie YAMMINE 20 Sep 2023 14 Sep 2024 Rachel DIXON 29 Mar 2022 29 Mar 2023 Melanie YAMMINE 29 Mar 2022 29 Mar 2023 Melanie YAMMINE 09 Nov 2018 09 Nov 2019 Complementary Information
None declared
Person in charge of EU relations
Ms Barbara McLaughlan (Director Government Affairs EMEA)
Person with legal responsibility
Mr Daniel Schulze (Senior Vice President & General Counsel)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
EFPIA
National pharmaceutical associationsMember organisations
EFPIA
National pharmaceutical associations -
Financial Data
Closed financial year
Apr 2017 - Mar 2018
Lobbying costs for closed financial year
250,000€
Other financial info
The estimated costs attributable to activities covered by the register include our Membership fees of EFPIA.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
We run a European Roundtable on combatting hospital infections with C-Difficile. All of our other engagement is currently through the European Federation of Pharmaceutical industries and Associations.
Other activities
None declared
Meetings
Meetings
None declared